{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:51:19Z","timestamp":1791093079900,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,9,30]],"date-time":"2013-09-30T00:00:00Z","timestamp":1380499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["DK079005"],"award-info":[{"award-number":["DK079005"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["DK34989"],"award-info":[{"award-number":["DK34989"]}]},{"name":"Silvio O. Conte Digestive Diseases Research Core Centers","award":["5P30DK034989NIH"],"award-info":[{"award-number":["5P30DK034989NIH"]}]},{"name":"Telethon","award":["GGP09189"],"award-info":[{"award-number":["GGP09189"]}]},{"name":"Liver Scholar Award (American Liver Foundation)"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Genetically determined loss of fibrocystin function causes congenital hepatic fibrosis (CHF), Caroli disease (CD), and autosomal recessive polycystic kidney disease (ARPKD). Cystic dysplasia of the intrahepatic bile ducts and progressive portal fibrosis characterize liver pathology in CHF\/CD. At a cellular level, several functional morphological and signaling changes have been reported including increased levels of 3\u2032-5\u2032-cyclic adenosine monophosphate (cAMP). In this study we addressed the relationships between increased cAMP and \u03b2-catenin. In cholangiocytes isolated and cultured from<\/jats:bold>\n                                 <jats:bold>\n                                    Pkhd1del4\/del4\n                                    \n                                 <\/jats:bold>\n                                 <jats:bold>mice, stimulation of cAMP\/PKA signaling (forskolin 10 \u03bcM) stimulated Ser675-phosphorylation of \u03b2-catenin, its nuclear localization, and its transcriptional activity (western blot and TOP flash assay, respectively) along with a down-regulation of E-cadherin expression (immunocytochemistry and western blot); these changes were inhibited by the PKA blocker, PKI (1 \u03bcM). The Rho-GTPase, Rac-1, was also significantly activated by cAMP in<\/jats:bold>\n                                 <jats:bold>\n                                    Pkhd1del4\/del4\n                                    \n                                 <\/jats:bold>\n                                 <jats:bold>cholangiocytes. Rac-1 inhibition blocked cAMP-dependent nuclear translocation and transcriptional activity of pSer675-\u03b2-catenin. Cell migration (Boyden chambers) was significantly higher in cholangiocytes obtained from<\/jats:bold>\n                                 <jats:bold>\n                                    Pkhd1del4\/del4\n                                    \n                                 <\/jats:bold>\n                                 <jats:bold>and was inhibited by: (1) PKI, (2) silencing \u03b2-catenin (siRNA), and (3) the Rac-1 inhibitor NSC 23766.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>These data show that in fibrocystin-defective cholangiocytes, cAMP\/PKA signaling stimulates pSer675-phosphorylation of \u03b2-catenin and Rac-1 activity. In the presence of activated Rac-1, pSer675-\u03b2-catenin is translocated to the nucleus, becomes transcriptionally active, and is responsible for increased motility of<\/jats:bold>\n                                 <jats:bold>\n                                    Pkhd1del4\/del4\n                                    \n                                 <\/jats:bold>\n                                 <jats:bold>cholangiocytes. \u03b2-Catenin-dependent changes in cell motility may be central to the pathogenesis of the disease and represent a potential therapeutic target. (Hepatology 2013;58:1713\u20131723)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26554","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T15:38:47Z","timestamp":1370533127000},"page":"1713-1723","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":41,"title":["Protein kinase a-dependent pSer675-\u03b2-catenin, a novel signaling defect in a mouse model of congenital hepatic fibrosis"],"prefix":"10.1097","volume":"58","author":[{"given":"Carlo","family":"Spirli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola M.","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Fiorotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Cadamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Strazzabosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-21-20241201","doi-asserted-by":"crossref","first-page":"259269","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptorlike protein.","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"key":"R3-21-20241201","doi-asserted-by":"crossref","first-page":"149168","DOI":"10.1038\/ki.2009.128","article-title":"Autosomal dominant polycystic kidney disease: the last 3 years.","volume":"76","author":"Torres","year":"2009","journal-title":"Kidney Int"},{"key":"R4-21-20241201","doi-asserted-by":"crossref","first-page":"F890899","DOI":"10.1152\/ajprenal.00341.2007","article-title":"Mechanoregulation of intracellular Ca2 in human autosomal recessive polycystic kidney disease cystlining renal epithelial cells.","volume":"294","author":"Rohatgi","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R5-21-20241201","doi-asserted-by":"crossref","first-page":"160174","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD).","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology"},{"key":"R6-21-20241201","doi-asserted-by":"crossref","first-page":"18191827","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKTmTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).","volume":"24","author":"Fischer","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R7-21-20241201","doi-asserted-by":"crossref","first-page":"11041116","DOI":"10.1053\/j.gastro.2006.12.039","article-title":"Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3,5cyclic monophosphate.","volume":"132","author":"Masyuk","year":"2007","journal-title":"Gastroenterology"},{"key":"R8-21-20241201","doi-asserted-by":"crossref","first-page":"90639072","DOI":"10.1128\/MCB.25.20.9063-9072.2005","article-title":"Phosphorylation of betacatenin by cyclic AMPdependent protein kinase stabilizes betacatenin through inhibition of its ubiquitination.","volume":"25","author":"Hino","year":"2005","journal-title":"Mol Cell Biol"},{"key":"R9-21-20241201","doi-asserted-by":"crossref","first-page":"99719976","DOI":"10.1074\/jbc.M508778200","article-title":"Phosphorylation of betacatenin by cyclic AMPdependent protein kinase.","volume":"281","author":"Taurin","year":"2006","journal-title":"J Biol Chem"},{"key":"R10-21-20241201","doi-asserted-by":"crossref","first-page":"C11691174","DOI":"10.1152\/ajpcell.00096.2008","article-title":"Phosphorylation of betacatenin by PKA promotes ATPinduced proliferation of vascular smooth muscle cells.","volume":"294","author":"Taurin","year":"2008","journal-title":"Am J Physiol Cell Physiol"},{"key":"R12-21-20241201","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1016\/j.canlet.2012.05.024","article-title":"Activation of canonical WNTbetacatenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelialtomesenchymal transition.","volume":"325","author":"Kahlert","year":"2012","journal-title":"Cancer Lett"},{"key":"R13-21-20241201","first-page":"12391248","article-title":"Apicobasal polarity in polycystic kidney disease epithelia.","volume":"1812","author":"Wilson","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R14-21-20241201","doi-asserted-by":"crossref","first-page":"27792789","DOI":"10.1007\/s00018-012-0951-3","article-title":"Ecadherin plays an essential role in collective directional migration of large epithelial sheets.","volume":"69","author":"Li","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"R15-21-20241201","doi-asserted-by":"crossref","first-page":"370374","DOI":"10.1007\/s00018-008-8552-x","article-title":"Rac1 GTPase: a Rac of all trades.","volume":"66","author":"Bosco","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"R16-21-20241201","doi-asserted-by":"crossref","first-page":"427444","DOI":"10.3109\/09687688.2011.603101","article-title":"Regulation of small GTPases at epithelial cellcell junctions.","volume":"28","author":"Citi","year":"2011","journal-title":"Mol Membr Biol"},{"key":"R17-21-20241201","doi-asserted-by":"crossref","first-page":"10011012","DOI":"10.1038\/onc.2011.294","article-title":"A Rac1PAK1 cascade controls betacatenin activation in colon cancer cells.","volume":"31","author":"Zhu","year":"2012","journal-title":"Oncogene"},{"key":"R18-21-20241201","doi-asserted-by":"crossref","first-page":"14831487","DOI":"10.1126\/science.1094291","article-title":"Convergence of Wnt, betacatenin, and cadherin pathways.","volume":"303","author":"Nelson","year":"2004","journal-title":"Science"},{"key":"R19-21-20241201","doi-asserted-by":"crossref","first-page":"23632374","DOI":"10.1002\/hep.25872","article-title":"Cyclic AMPPKAdependent paradoxical activation of RafMEKERK signaling in polycystin2 defective mice treated with sorafenib.","volume":"56","author":"Spirli","year":"2012","journal-title":"Hepatology"},{"key":"R20-21-20241201","doi-asserted-by":"crossref","first-page":"856868","DOI":"10.1002\/hep.24723","article-title":"Altered store operated calcium entry increases cyclic 3,5adenosine monophosphate production and extracellular signalregulated kinases 1 and 2 phosphorylation in polycystin2defective cholangiocytes.","volume":"55","author":"Spirli","year":"2012","journal-title":"Hepatology"},{"key":"R21-21-20241201","doi-asserted-by":"crossref","first-page":"17781788","DOI":"10.1002\/hep.23511","article-title":"Mammalian target of rapamycin regulates vascular endothelial growth factordependent liver cyst growth in polycystin2defective mice.","volume":"51","author":"Spirli","year":"2010","journal-title":"Hepatology"},{"key":"R22-21-20241201","doi-asserted-by":"crossref","first-page":"360371","DOI":"10.1053\/j.gastro.2009.09.005","article-title":"ERK12dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin2 defective mice.","volume":"138","author":"Spirli","year":"2010","journal-title":"Gastroenterology"},{"key":"R23-21-20241201","doi-asserted-by":"crossref","first-page":"417429","DOI":"10.2353\/ajpath.2008.070381","article-title":"Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1.","volume":"172","author":"Gallagher","year":"2008","journal-title":"Am J Pathol"},{"key":"R24-21-20241201","doi-asserted-by":"crossref","first-page":"31053117","DOI":"10.1093\/hmg\/ddn208","article-title":"Polycystin1 Cterminal tail associates with betacatenin and inhibits canonical Wnt signaling.","volume":"17","author":"Lal","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R25-21-20241201","doi-asserted-by":"crossref","first-page":"17191730","DOI":"10.1016\/S0002-9440(10)63427-X","article-title":"Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease.","volume":"165","author":"Masyuk","year":"2004","journal-title":"Am J Pathol"},{"key":"R28-21-20241201","doi-asserted-by":"crossref","first-page":"151166","DOI":"10.1007\/s10555-008-9179-y","article-title":"Ecadherin, betacatenin, and ZEB1 in malignant progression of cancer.","volume":"28","author":"Schmalhofer","year":"2009","journal-title":"Cancer Metastasis Rev"},{"key":"R29-21-20241201","doi-asserted-by":"crossref","first-page":"633643","DOI":"10.1038\/nrm2957","article-title":"Cell adhesion: integrating cytoskeletal dynamics and cellular tension.","volume":"11","author":"Parsons","year":"2010","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R30-21-20241201","doi-asserted-by":"crossref","first-page":"321337","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease.","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"key":"R31-21-20241201","doi-asserted-by":"crossref","first-page":"25322542","DOI":"10.1093\/hmg\/ddp190","article-title":"Toxic tubular injury in kidneys from Pkd1deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.","volume":"18","author":"Happe","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R32-21-20241201","doi-asserted-by":"crossref","first-page":"146153","DOI":"10.1038\/ki.2011.56","article-title":"Tcell factorbetacatenin activity is suppressed in two different models of autosomal dominant polycystic kidney disease.","volume":"80","author":"Miller","year":"2011","journal-title":"Kidney Int"},{"key":"R33-21-20241201","doi-asserted-by":"crossref","first-page":"13091318","DOI":"10.1681\/ASN.2011030277","article-title":"cMet and NFkappaBdependent overexpression of Wnt7a and 7b and Pax2 promotes cystogenesis in polycystic kidney disease.","volume":"23","author":"Qin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R34-21-20241201","doi-asserted-by":"crossref","first-page":"135138","DOI":"10.1038\/ki.2011.87","article-title":"WNTbetacatenin signaling in polycystic kidney disease.","volume":"80","author":"Wuebken","year":"2011","journal-title":"Kidney Int"},{"key":"R37-21-20241201","doi-asserted-by":"crossref","first-page":"984991","DOI":"10.1038\/embor.2012.149","article-title":"Fellow travellers: emergent properties of collective cell migration.","volume":"13","author":"Rorth","year":"2012","journal-title":"EMBO Rep"},{"key":"R38-21-20241201","doi-asserted-by":"crossref","first-page":"17961813","DOI":"10.1128\/MCB.01423-08","article-title":"A Rac GTPaseactivating protein, MgcRacGAP, is a nuclear localizing signalcontaining nuclear chaperone in the activation of STAT transcription factors.","volume":"29","author":"Kawashima","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R39-21-20241201","doi-asserted-by":"crossref","first-page":"634664","DOI":"10.2174\/138161213804581837","article-title":"Wntbetacatenin signaling and small molecule inhibitors.","volume":"19","author":"Voronkov","year":"2013","journal-title":"Curr Pharm Des"}],"updated-by":[{"DOI":"10.1097\/hep.0000000000000486","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"record-id":"46221"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26554","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26554","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201311000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:14:45Z","timestamp":1733062485000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201311000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26554","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}